Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: BMJ Publishing Group 2020-12-01
Series:BMJ Open Gastroenterology
Online Access:https://bmjopengastro.bmj.com/content/7/1/e000302corr1.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846122260960641024
collection DOAJ
format Article
id doaj-art-8c2a20ba654342378e9d20c49d11db27
institution Kabale University
issn 2054-4774
language English
publishDate 2020-12-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Gastroenterology
spelling doaj-art-8c2a20ba654342378e9d20c49d11db272024-12-14T20:20:07ZengBMJ Publishing GroupBMJ Open Gastroenterology2054-47742020-12-017110.1136/bmjgast-2019-000302corr1Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluationhttps://bmjopengastro.bmj.com/content/7/1/e000302corr1.full
spellingShingle Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
BMJ Open Gastroenterology
title Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
title_full Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
title_fullStr Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
title_full_unstemmed Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
title_short Correction: Tofacitinib for the treatment of moderately to severely active ulcerative colitis: a systematic review, network meta-analysis and economic evaluation
title_sort correction tofacitinib for the treatment of moderately to severely active ulcerative colitis a systematic review network meta analysis and economic evaluation
url https://bmjopengastro.bmj.com/content/7/1/e000302corr1.full